Michael Igel

1.9k total citations · 1 hit paper
18 papers, 1.5k citations indexed

About

Michael Igel is a scholar working on Endocrine and Autonomic Systems, Surgery and Epidemiology. According to data from OpenAlex, Michael Igel has authored 18 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Endocrine and Autonomic Systems, 7 papers in Surgery and 6 papers in Epidemiology. Recurrent topics in Michael Igel's work include Regulation of Appetite and Obesity (8 papers), Adipokines, Inflammation, and Metabolic Diseases (5 papers) and Cholesterol and Lipid Metabolism (4 papers). Michael Igel is often cited by papers focused on Regulation of Appetite and Obesity (8 papers), Adipokines, Inflammation, and Metabolic Diseases (5 papers) and Cholesterol and Lipid Metabolism (4 papers). Michael Igel collaborates with scholars based in Germany, United States and Finland. Michael Igel's co-authors include Klaus von Bergmann, Thomas Sudhop, Dieter Lütjohann, Inna Perevozskaya, Diane L. Tribble, Sukrut Shah, Hans‐Georg Joost, L. Herberg, Walter Becker and Hans Törnqvist and has published in prestigious journals such as Circulation, Gastroenterology and Endocrinology.

In The Last Decade

Michael Igel

18 papers receiving 1.4k citations

Hit Papers

Inhibition of Intestinal Cholesterol Absorption by Ezetim... 2002 2026 2010 2018 2002 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Inhibition of Intestinal Cholesterol Absorption by Ezetimibe in Humans
    2002 527 citations Thomas Sudhop, Dieter Lütjohann et al. Circulation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Igel Germany 13 883 325 284 245 239 18 1.5k
Anna Jamróz-Wiśniewska Poland 20 379 0.4× 104 0.3× 293 1.0× 160 0.7× 338 1.4× 60 1.4k
Cecilia Morgantini Canada 18 443 0.5× 71 0.2× 334 1.2× 587 2.4× 331 1.4× 29 1.3k
S. Balasubramaniam Australia 18 690 0.8× 143 0.4× 364 1.3× 465 1.9× 206 0.9× 33 1.4k
Anuradha S. Pappu United States 25 688 0.8× 150 0.5× 638 2.2× 253 1.0× 266 1.1× 50 1.5k
Bhalchandra J. Kudchodkar United States 23 571 0.6× 124 0.4× 296 1.0× 321 1.3× 182 0.8× 57 1.2k
Erez Scapa Israel 14 490 0.6× 188 0.6× 536 1.9× 278 1.1× 276 1.2× 45 1.7k
Patricia K. Eagon United States 29 570 0.6× 280 0.9× 458 1.6× 382 1.6× 105 0.4× 69 2.0k
Michal Vráblík Czechia 26 946 1.1× 82 0.3× 343 1.2× 501 2.0× 171 0.7× 167 2.0k
Gianluca Bardini Italy 20 432 0.5× 180 0.6× 491 1.7× 1.1k 4.3× 237 1.0× 40 1.6k
Marisa Passarelli Brazil 27 483 0.5× 87 0.3× 469 1.7× 697 2.8× 341 1.4× 105 1.8k

Countries citing papers authored by Michael Igel

Since Specialization
Citations

This map shows the geographic impact of Michael Igel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Igel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Igel more than expected).

Fields of papers citing papers by Michael Igel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Igel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Igel. The network helps show where Michael Igel may publish in the future.

Co-authorship network of co-authors of Michael Igel

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Igel. A scholar is included among the top collaborators of Michael Igel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Igel. Michael Igel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Weber, Florian, et al.. (2016). Analyse des öffentlichen Diskurses zu gesundheitlichen Auswirkungen von Hochspannungsleitungen : Handlungsempfehlungen für die strahlenschutzbezogene Kommunikation beim Stromnetzausbau : Vorhaben 3614S80008. 3 indexed citations
2.
Igel, Michael, Katrin Arnold, Mikko Niemi, et al.. (2006). Impact of the SLCO1B1 polymorphism on the pharmacokinetics and lipid-lowering efficacy of multiple-dose pravastatin. Clinical Pharmacology & Therapeutics. 79(5). 419–426. 82 indexed citations
3.
Schmitt‐Grohé, Sabina, Michael Igel, Klaus von Bergmann, et al.. (2006). Serum Leptin and Cytokines in Whole Blood in Relation to Clinical and Nutritional Status in Cystic Fibrosis. Journal of Pediatric Gastroenterology and Nutrition. 43(2). 228–233. 14 indexed citations
4.
Igel, Michael, et al.. (2005). Ratio of lathosterol to campesterol in serum predicts the cholesterol-lowering effect of sitostanol-supplemented margarine. International Journal of Clinical Pharmacology and Therapeutics. 43(7). 305–310. 20 indexed citations
5.
Schmitt‐Grohé, Sabina, Michael Igel, Andreas Krahl, et al.. (2005). Lipopolysaccharide Binding Protein, Cytokine Production in Whole Blood, and Lipoproteins in Cystic Fibrosis. Pediatric Research. 58(5). 903–907. 7 indexed citations
6.
Raab, Peter, et al.. (2004). Cholesterol metabolism in patients with chronic renal failure on hemodialysis.. PubMed. 16(6). 850–4. 9 indexed citations
7.
Igel, Michael, et al.. (2003). Comparison of the intestinal uptake of cholesterol, plant sterols, and stanols in mice. Journal of Lipid Research. 44(3). 533–538. 81 indexed citations
8.
Igel, Michael, Thomas Sudhop, & Klaus von Bergmann. (2002). Pharmacology of 3‐Hydroxy‐3‐Methylglutaryl‐Coenzyme A Reductase Inhibitors (Statins), Including Rosuvastatin and Pitavastatin. The Journal of Clinical Pharmacology. 42(8). 835–845. 76 indexed citations
9.
Igel, Michael, et al.. (2002). Evidence that leptin contributes to intestinal cholesterol absorption in obese (ob/ob) mice and wild‐type mice. Lipids. 37(2). 153–157. 12 indexed citations
10.
Sudhop, Thomas, Dieter Lütjohann, Michael Igel, et al.. (2002). Inhibition of Intestinal Cholesterol Absorption by Ezetimibe in Humans. Circulation. 106(15). 1943–1948. 527 indexed citations breakdown →
11.
Drobnik, Wolfgang, B. Lindenthal, Mirko Ritter, et al.. (2001). ATP-binding cassette transporter A1 (ABCA1) affects total body sterol metabolism. Gastroenterology. 120(5). 1203–1211. 112 indexed citations
12.
Igel, Michael, Thomas Sudhop, & Klaus von Bergmann. (2001). Metabolism and drug interactions of 3-hydroxy-3-methylglutaryl coenzyme A-reductase inhibitors (statins). European Journal of Clinical Pharmacology. 57(5). 357–364. 139 indexed citations
13.
Bornstein, SR, Elizabeth Webster, David J. Torpy, et al.. (1998). Chronic Effects of a Nonpeptide Corticotropin-Releasing Hormone Type I Receptor Antagonist on Pituitary-Adrenal Function, Body Weight, and Metabolic Regulation1. Endocrinology. 139(4). 1546–1555. 90 indexed citations
14.
Igel, Michael, et al.. (1998). Hyperleptinemia and leptin receptor variant Asp600Asn in the obese, hyperinsulinemic KK mouse strain. Journal of Molecular Endocrinology. 21(3). 337–345. 17 indexed citations
15.
Igel, Michael, Walter Becker, L. Herberg, & Hans‐Georg Joost. (1997). Hyperleptinemia, Leptin Resistance, and Polymorphic Leptin Receptor in the New Zealand Obese Mouse*. Endocrinology. 138(10). 4234–4239. 71 indexed citations
16.
Igel, Michael, et al.. (1996). Difference in Leptin mRNA Levels Between Omental and Subcutaneous Abdominal Adipose Tissue From Obese Humans. Hormone and Metabolic Research. 28(12). 690–693. 193 indexed citations
17.
Igel, Michael, Heikki Kainulainen, A. Brauers, et al.. (1996). Long-term and rapid regulation of ob mRNA levels in adipose tissue from normal (Sprague Dawley rats) and obese [db/db mice, fa/fa rats) rodents. Diabetologia. 39(7). 758–765. 40 indexed citations
18.
Igel, Michael, Walter Becker, L. Herberg, & Hans‐Georg Joost. (1996). Evidence that Reduced Leptin Levels, but Not an Aberrant Sequence of Leptin or its Receptor, Contribute to the Obesity Syndrome in NON Mice. Hormone and Metabolic Research. 28(12). 669–673. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Jamróz-Wiśniewska Breakdown of academic impact, for papers by Cecilia Morgantini Breakdown of academic impact, for papers by S. Balasubramaniam Breakdown of academic impact, for papers by Anuradha S. Pappu Breakdown of academic impact, for papers by Bhalchandra J. Kudchodkar Breakdown of academic impact, for papers by Erez Scapa Breakdown of academic impact, for papers by Patricia K. Eagon Breakdown of academic impact, for papers by Michal Vráblík Breakdown of academic impact, for papers by Gianluca Bardini Breakdown of academic impact, for papers by Marisa Passarelli
Rankless by CCL
2026